These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
318 related articles for article (PubMed ID: 28612228)
1. Pleomorphic lobular carcinoma in situ of the breast: a single institution experience with clinical follow-up and centralized pathology review. De Brot M; Koslow Mautner S; Muhsen S; Andrade VP; Mamtani A; Murray M; Giri D; Sakr RA; Brogi E; King TA Breast Cancer Res Treat; 2017 Sep; 165(2):411-420. PubMed ID: 28612228 [TBL] [Abstract][Full Text] [Related]
2. Treatment Outcomes for Pleomorphic Lobular Carcinoma In Situ of the Breast. Desai AA; Jimenez RE; Hoskin TL; Day CN; Boughey JC; Hieken TJ Ann Surg Oncol; 2018 Oct; 25(10):3064-3068. PubMed ID: 29947004 [TBL] [Abstract][Full Text] [Related]
3. Evaluating agreement, histological features, and relevance of separating pleomorphic and florid lobular carcinoma in situ subtypes. Singh K; Paquette C; Kalife ET; Wang Y; Mangray S; Quddus MR; Steinhoff MM Hum Pathol; 2018 Aug; 78():163-170. PubMed ID: 29753007 [TBL] [Abstract][Full Text] [Related]
4. Characteristics and clinical outcomes of pleomorphic lobular carcinoma in situ of the breast. Fasola CE; Chen JJ; Jensen KC; Allison KH; Horst KC Breast J; 2018 Jan; 24(1):66-69. PubMed ID: 28929550 [TBL] [Abstract][Full Text] [Related]
5. Evaluating the Rate of Upgrade to Invasive Breast Cancer and/or Ductal Carcinoma In Situ Following a Core Biopsy Diagnosis of Non-classic Lobular Carcinoma In Situ. Nakhlis F; Harrison BT; Giess CS; Lester SC; Hughes KS; Coopey SB; King TA Ann Surg Oncol; 2019 Jan; 26(1):55-61. PubMed ID: 30362065 [TBL] [Abstract][Full Text] [Related]
6. The Pathologic Finding of Combined Lobular Carcinoma Jean-Louis CJ; Masdon J; Smith B; Battles O; Dale P Am Surg; 2017 May; 83(5):482-485. PubMed ID: 28541858 [TBL] [Abstract][Full Text] [Related]
7. Pleomorphic Lobular Carcinoma In Situ: Imaging Features, Upgrade Rate, and Clinical Outcomes. Savage JL; Jeffries DO; Noroozian M; Sabel MS; Jorns JM; Helvie MA AJR Am J Roentgenol; 2018 Aug; 211(2):462-467. PubMed ID: 29894223 [TBL] [Abstract][Full Text] [Related]
8. Pleomorphic and Florid Lobular Carcinoma In Situ Variants of the Breast: A Clinicopathologic Study of 85 Cases With and Without Invasive Carcinoma From a Single Academic Center. Shamir ER; Chen YY; Chu T; Pekmezci M; Rabban JT; Krings G Am J Surg Pathol; 2019 Mar; 43(3):399-408. PubMed ID: 30489319 [TBL] [Abstract][Full Text] [Related]
9. Pleomorphic LCIS what do we know? A UK multicenter audit of pleomorphic lobular carcinoma in situ. Masannat YA; Husain E; Roylance R; Heys SD; Carder PJ; Ali H; Maurice Y; Pinder SE; Sawyer E; Shaaban AM Breast; 2018 Apr; 38():120-124. PubMed ID: 29310036 [TBL] [Abstract][Full Text] [Related]
10. Pleomorphic Lobular Carcinoma in Situ Diagnosed by Breast Core Biopsy: Clinicopathologic Features and Correlation With Subsequent Excision. Guo T; Wang Y; Shapiro N; Fineberg S Clin Breast Cancer; 2018 Aug; 18(4):e449-e454. PubMed ID: 29102711 [TBL] [Abstract][Full Text] [Related]
11. When pathological and radiological correlation is achieved, excision of fibroadenoma with lobular neoplasia on core biopsy is not warranted. Fives C; O'Neill CJ; Murphy R; Corrigan MA; O'Sullivan MJ; Feeley L; Bennett MW; O'Connell F; Browne TJ Breast; 2016 Dec; 30():125-129. PubMed ID: 27718416 [TBL] [Abstract][Full Text] [Related]
12. Pleomorphic Lobular Carcinoma In Situ: Radiologic-Pathologic Features and Clinical Management. Flanagan MR; Rendi MH; Calhoun KE; Anderson BO; Javid SH Ann Surg Oncol; 2015 Dec; 22(13):4263-9. PubMed ID: 25893410 [TBL] [Abstract][Full Text] [Related]
13. Screen-detected pleomorphic lobular carcinoma in situ (PLCIS): risk of concurrent invasive malignancy following a core biopsy diagnosis. Carder PJ; Shaaban A; Alizadeh Y; Kumarasuwamy V; Liston JC; Sharma N Histopathology; 2010 Sep; 57(3):472-8. PubMed ID: 20727019 [TBL] [Abstract][Full Text] [Related]
14. Lobular carcinoma in situ: observation without surgery as an appropriate therapy. Carson W; Sanchez-Forgach E; Stomper P; Penetrante R; Tsangaris TN; Edge SB Ann Surg Oncol; 1994 Mar; 1(2):141-6. PubMed ID: 7834439 [TBL] [Abstract][Full Text] [Related]
15. Lobular Carcinoma in Situ: A 29-Year Longitudinal Experience Evaluating Clinicopathologic Features and Breast Cancer Risk. King TA; Pilewskie M; Muhsen S; Patil S; Mautner SK; Park A; Oskar S; Guerini-Rocco E; Boafo C; Gooch JC; De Brot M; Reis-Filho JS; Morrogh M; Andrade VP; Sakr RA; Morrow M J Clin Oncol; 2015 Nov; 33(33):3945-52. PubMed ID: 26371145 [TBL] [Abstract][Full Text] [Related]
16. Genetic analysis of pleomorphic and florid lobular carcinoma in situ variants: frequent ERBB2/ERBB3 alterations and clonal relationship to classic lobular carcinoma in situ and invasive lobular carcinoma. Shamir ER; Chen YY; Krings G Mod Pathol; 2020 Jun; 33(6):1078-1091. PubMed ID: 31907376 [TBL] [Abstract][Full Text] [Related]
17. Clinical, histopathologic, and biologic features of pleomorphic lobular (ductal-lobular) carcinoma in situ of the breast: a report of 24 cases. Sneige N; Wang J; Baker BA; Krishnamurthy S; Middleton LP Mod Pathol; 2002 Oct; 15(10):1044-50. PubMed ID: 12379750 [TBL] [Abstract][Full Text] [Related]
18. Breast-conserving surgery for pure non-classic lobular carcinoma in situ: A single institution's experience. Hoffman DI; Zhang PJ; Tchou J Surg Oncol; 2019 Mar; 28():190-194. PubMed ID: 30851899 [TBL] [Abstract][Full Text] [Related]
19. Long term clinical follow-up of atypical ductal hyperplasia and lobular carcinoma in situ in breast core needle biopsies. Renshaw AA; Gould EW Pathology; 2016 Jan; 48(1):25-9. PubMed ID: 27020205 [TBL] [Abstract][Full Text] [Related]
20. Descriptive study comparing outcomes of classic and nonclassic lobular carcinoma in situ (florid and pleomorphic) initially diagnosed on core needle biopsy. Singh K; Sung CJ; Quddus MR Breast J; 2020 Dec; 26(12):2350-2356. PubMed ID: 33047861 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]